{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:05:34Z","timestamp":1792145134529,"version":"4.4.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0152498","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T17:56:55Z","timestamp":1459447015000},"page":"e0152498","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":92,"title":["The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington\u2019s Disease Mice"],"prefix":"10.1371","volume":"11","author":[{"given":"Haiqun","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Gottesfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Rusche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","article-title":"Therapeutic application of histone deacetylase inhibitors for central nervous system disorders","volume":"7","author":"AG Kazantsev","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1517\/13543784.17.2.169","article-title":"Histone deacetylase inhibitors: possible implications for neurodegenerative disorders","volume":"17","author":"E Hahnen","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group","volume":"72","year":"1993","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3390\/ph7060634","article-title":"Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1\/HDAC3 Inhibitors","volume":"7","author":"EA Thomas","year":"2014","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.canlet.2009.02.013","article-title":"Isoform-specific histone deacetylase inhibitors: the next step?","volume":"280","author":"S Balasubramanian","year":"2009","journal-title":"Cancer Lett"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jmb.2004.02.006","article-title":"Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis","volume":"338","author":"IV Gregoretti","year":"2004","journal-title":"Journal of molecular biology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1523\/JNEUROSCI.5704-10.2011","article-title":"Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta","volume":"31","author":"FH Bardai","year":"2011","journal-title":"J Neurosci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"35444","DOI":"10.1074\/jbc.M112.394544","article-title":"Histone deacetylase (HDAC1) is a molecular switch between neuronal survival and death","volume":"287","author":"FH Bardai","year":"2012","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"11833","DOI":"10.1523\/JNEUROSCI.5831-12.2013","article-title":"Disassociation of histone deacetylase-3 from normal huntingtin underlies mutant huntingtin neurotoxicity","volume":"33","author":"FH Bardai","year":"2013","journal-title":"J Neurosci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"E2865","DOI":"10.1073\/pnas.1121131109","article-title":"Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages","volume":"109","author":"X Chen","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"25844","DOI":"10.1074\/jbc.M112.348284","article-title":"Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein","volume":"287","author":"Y Kim","year":"2012","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"541259","DOI":"10.1155\/2013\/541259","article-title":"The role of the immune system in Huntington's disease","volume":"2013","author":"G Ellrichmann","year":"2013","journal-title":"Clinical & developmental immunology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington's disease","volume":"20","author":"A Silvestroni","year":"2009","journal-title":"Neuroreport"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"A Dalrymple","year":"2007","journal-title":"J Proteome Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"M Bjorkqvist","year":"2008","journal-title":"J Exp Med"},{"issue":"24","key":"ref16","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.1093\/hmg\/dds379","article-title":"Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington's disease mice: implications for the ubiquitin-proteasomal and autophagy systems","volume":"21","author":"H Jia","year":"2012","journal-title":"Hum Mol Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.1073\/pnas.1415195112","article-title":"HDAC inhibition imparts beneficial transgenerational effects in Huntington's disease mice via altered DNA and histone methylation","volume":"112","author":"H Jia","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.nbd.2012.01.016","article-title":"Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease","volume":"46","author":"H Jia","year":"2012","journal-title":"Neurobiol Dis"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC Inhibitor, 4b, Ameliorates the Disease Phenotype and Transcriptional Abnormalities in Huntington's Disease Transgenic Mice","volume":"105","author":"EA Thomas","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","article-title":"HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner","author":"M Malvaez","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbi.2013.01.086","article-title":"Epigenetic changes at gene promoters in response to immune activation in utero","volume":"30","author":"B Tang","year":"2013","journal-title":"Brain Behav Immun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1471-4159.2001.00027.x","article-title":"Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy","volume":"76","author":"EA Thomas","year":"2001","journal-title":"J Neurochem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/npp.2015.93","article-title":"Pharmacological Selectivity Within Class I Histone Deacetylases Predicts Effects on Synaptic Function and Memory Rescue","volume":"40","author":"G Rumbaugh","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Jia H, Pallos J, Jacques V, Lau A, Tang B, Cooper A, et al. Histone deacetylase inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in Huntington\u2019s disease model systems. CHDI. 2012; 7th Annual Huntington's Disease Therapeutics Conference: A Forum for Drug Discovery & Development","DOI":"10.1016\/j.nbd.2012.01.016"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.4049\/jimmunol.1200485","article-title":"Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation","volume":"191","author":"GM Cox","year":"2013","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1460-9568.2000.00914.x","article-title":"Neuronal and vascular localization of histamine N-methyltransferase in the bovine central nervous system","volume":"12","author":"M Nishibori","year":"2000","journal-title":"Eur J Neurosci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(98)00203-1","article-title":"Identification of macrophage migration inhibitory factor mRNA expression in neural cells of the rat brain by in situ hybridization","volume":"246","author":"A Ogata","year":"1998","journal-title":"Neurosci Lett"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e92325","DOI":"10.1371\/journal.pone.0092325","article-title":"Human astrocytes: secretome profiles of cytokines and chemokines","volume":"9","author":"SS Choi","year":"2014","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2377-12-47","article-title":"Huntington's disease and its therapeutic target genes: a global functional profile based on the HD Research Crossroads database","volume":"12","author":"RK Kalathur","year":"2012","journal-title":"BMC neurology"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1172","article-title":"Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6\/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model","volume":"2","author":"L Quinti","year":"2010","journal-title":"PLoS currents"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e31080","DOI":"10.1371\/journal.pone.0031080","article-title":"Genetic knock-down of HDAC3 does not modify disease-related phenotypes in a mouse model of Huntington's disease","volume":"7","author":"L Moumne","year":"2012","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"14085","DOI":"10.3390\/molecules181114085","article-title":"The histone deacetylase inhibitors MS-275 and SAHA suppress the p38 mitogen-activated protein kinase signaling pathway and chemotaxis in rheumatoid arthritic synovial fibroblastic E11 cells","volume":"18","author":"QY Choo","year":"2013","journal-title":"Molecules (Basel, Switzerland)"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gene.2005.09.010","article-title":"Acetylation and deacetylation of non-histone proteins","volume":"363","author":"MA Glozak","year":"2005","journal-title":"Gene"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1128\/MCB.00882-06","article-title":"Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2","volume":"27","author":"S Gregoire","year":"2007","journal-title":"Mol Cell Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1062374","article-title":"Duration of nuclear NF-kappaB action regulated by reversible acetylation","volume":"293","author":"L Chen","year":"2001","journal-title":"Science"},{"key":"ref36","article-title":"Histone deacetylase isoforms regulate innate immune responses by deacetylating mitogen-activated protein kinase phosphatase-1","author":"Y Jeong","year":"2013","journal-title":"Journal of leukocyte biology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12974-015-0396-3","article-title":"Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease","volume":"12","author":"SQ Li","year":"2015","journal-title":"J Neuroinflammation"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"E Hockly","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease","volume":"280","author":"G Gardian","year":"2005","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cell.2009.03.018","article-title":"Acetylation targets mutant huntingtin to autophagosomes for degradation","volume":"137","author":"H Jeong","year":"2009","journal-title":"Cell"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0152498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T11:15:33Z","timestamp":1589022933000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0152498"}},"subtitle":[],"editor":[{"given":"Gary L.","family":"Dunbar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0152498","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}